-
Krystal Biotech Reports Third Quarter 2020 Financial Results
Post on 11/9/20
-
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
Post on 11/9/20
-
Homology Medicines Announces $60 Million Equity Investment from Pfizer
Post on 11/9/20
-
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
Post on 11/9/20
-
Genesis Healthcare Reports Third Quarter 2020 Results
Post on 11/9/20
-
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
Post on 11/9/20
-
Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks
Post on 11/9/20
-
3 Red Flags for Inovio Pharmaceuticals' Future
Post on 11/9/20
-
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
Post on 11/6/20
-
Genesis Healthcare to Release Third Quarter 2020 Results and Provide COVID-19 Update
Post on 11/6/20
-
Ocugen Provides Business Update and Third Quarter 2020 Financial Results
Post on 11/6/20
-
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
Post on 11/6/20
-
Merck Makes a $2.8 Billion Bet on an Experimental New Cancer Drug
Post on 11/6/20
-
Caladrius Biosciences Provides Corporate Update
Post on 11/5/20
-
CorMedix Provides Business Update
Post on 11/5/20
-
Celldex Provides Corporate Update
Post on 11/5/20
-
BD Announces Fiscal Fourth Quarter And Full Year 2020 Results
Post on 11/5/20
-
AmerisourceBergen Reports Fiscal 2020 Fourth Quarter and Year End Results
Post on 11/5/20
-
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
Post on 11/5/20
-
Outlook Therapeutics Secures $10 Million
Post on 11/5/20
-
VYNE Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Post on 11/5/20
-
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
Post on 11/5/20
-
Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
Post on 11/5/20
-
AdaptHealth Announces Third Quarter 2020 Financial Results
Post on 11/4/20
-
Aclaris Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
Post on 11/4/20
Philadelphia
